Q3 2023 · 13F-HR
Ikarian Capital, LLCholdings as filed
Filed 2023-11-14 · accession 0001420506-23-002207
$831.4M
Reported value
140
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $64.1M | 7.71% | 1,500 | PUT | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $44.5M | 5.36% | 3,673 | PUT | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $43.0M | 5.17% | 1,200 | PUT | SOLE |
| 78464A870 | XBI | SPDR SER TR | $36.5M | 4.39% | 5,000 | PUT | SOLE |
| 00445A100 | — | ACELYRIN INC | $29.7M | 3.57% | 2,918,426 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $27.8M | 3.34% | 7,230 | CALL | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $25.7M | 3.10% | 2,123 | CALL | SOLE |
| 60770K107 | MRNA | MODERNA INC | $25.2M | 3.04% | 2,443 | PUT | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $23.6M | 2.84% | 792,920 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $21.2M | 2.56% | 5,534 | PUT | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $19.8M | 2.38% | 1,325 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $15.8M | 1.91% | 536,720 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $15.4M | 1.86% | 3,049 | PUT | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $13.5M | 1.63% | 4,543 | PUT | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $13.4M | 1.61% | 654,726 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $12.8M | 1.54% | 278,034 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $12.5M | 1.50% | 473,126 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $12.1M | 1.45% | 4,054 | CALL | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $11.4M | 1.38% | 297,794 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $11.0M | 1.32% | 2,395 | CALL | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $10.9M | 1.31% | 7,500 | PUT | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $10.1M | 1.22% | 200,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $10.1M | 1.21% | 1,989 | CALL | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $9.8M | 1.18% | 845 | PUT | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $9.3M | 1.12% | 5,438 | PUT | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $9.3M | 1.11% | 2,039 | PUT | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $9.2M | 1.11% | 518,519 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $9.0M | 1.08% | 1,018 | PUT | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $9.0M | 1.08% | 2,365 | CALL | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $8.8M | 1.06% | 12,132 | PUT | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $8.1M | 0.97% | 3,054 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $7.3M | 0.87% | 142,417 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $7.2M | 0.86% | 4,000 | CALL | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $7.2M | 0.86% | 1,526 | PUT | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $6.9M | 0.84% | 137,824 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $6.7M | 0.81% | 142,766 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $6.2M | 0.75% | 174,945 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $6.2M | 0.74% | 390,162 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $6.0M | 0.72% | 746,069 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $6.0M | 0.72% | 2,035 | CALL | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $6.0M | 0.72% | 2,035 | PUT | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $5.9M | 0.71% | 505,862 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $5.9M | 0.70% | 216,949 | Common | SOLE |
| 02290A102 | — | AMBRX BIOPHARMA INC | $5.7M | 0.68% | 4,932 | CALL | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $5.7M | 0.68% | 3,568 | CALL | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $5.6M | 0.68% | 2,035 | PUT | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $5.4M | 0.65% | 418 | CALL | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $5.4M | 0.65% | 3,504 | CALL | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $5.2M | 0.62% | 7,132 | CALL | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $4.9M | 0.59% | 1,254,384 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $4.6M | 0.55% | 254,876 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $4.3M | 0.52% | 1,233 | PUT | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $4.1M | 0.50% | 178,360 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $4.1M | 0.49% | 5,955 | PUT | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $4.0M | 0.48% | 2,325 | CALL | SOLE |
| 457669307 | INSM | INSMED INC | $3.9M | 0.47% | 154,900 | Common | SOLE |
| 74006W108 | — | PRAXIS PRECISION MEDICINES I | $3.8M | 0.46% | 2,250,000 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $3.8M | 0.46% | 346,471 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $3.8M | 0.45% | 2,065 | CALL | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $3.6M | 0.44% | 2,500 | CALL | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $3.6M | 0.43% | 4,487 | PUT | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $3.3M | 0.40% | 3,056 | CALL | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $3.3M | 0.40% | 2,230 | CALL | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $3.2M | 0.39% | 865,787 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $3.2M | 0.38% | 2,413 | PUT | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $3.1M | 0.37% | 1,500 | CALL | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $2.9M | 0.34% | 514,101 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $2.8M | 0.34% | 374,807 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $2.8M | 0.33% | 106,138 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $2.7M | 0.32% | 682,868 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $2.7M | 0.32% | 971 | PUT | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $2.7M | 0.32% | 2,000 | CALL | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $2.5M | 0.30% | 3,637 | CALL | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $2.5M | 0.30% | 5,095 | CALL | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $2.4M | 0.29% | 2,726 | CALL | SOLE |
| 670703107 | NUVL | NUVALENT INC | $2.4M | 0.29% | 523 | PUT | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $2.4M | 0.29% | 305,857 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $2.1M | 0.25% | 688,604 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $2.0M | 0.24% | 1,579,770 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $1.8M | 0.21% | 787,056 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $1.7M | 0.20% | 1,737,636 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $1.6M | 0.20% | 1,222,852 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $1.6M | 0.19% | 555,572 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.6M | 0.19% | 412 | PUT | SOLE |
| 09074F207 | — | BIOVIE INC | $1.6M | 0.19% | 457,345 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $1.6M | 0.19% | 104,300 | Common | SOLE |
| 00791X100 | — | AEON BIOPHARMA INC | $1.4M | 0.17% | 257,977 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.4M | 0.17% | 462,828 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $1.4M | 0.17% | 1,369 | CALL | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $1.4M | 0.17% | 30,546 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.4M | 0.17% | 142,692 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $1.3M | 0.16% | 284 | CALL | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $1.3M | 0.16% | 195,899 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $1.3M | 0.16% | 315,265 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $1.2M | 0.15% | 816 | PUT | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $1.2M | 0.14% | 229,100 | Common | SOLE |
| 05455M100 | — | AVROBIO INC | $1.1M | 0.13% | 718,259 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.1M | 0.13% | 157,365 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $1.0M | 0.12% | 853,391 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.0M | 0.12% | 2,000 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $832,365 | 0.10% | 165,480 | Common | SOLE |
| 471871103 | — | JASPER THERAPEUTICS INC | $787,561 | 0.09% | 1,125,087 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $776,527 | 0.09% | 1,171,939 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $663,301 | 0.08% | 48,170 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $661,501 | 0.08% | 450,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $659,058 | 0.08% | 1,227 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $614,412 | 0.07% | 472,625 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $612,078 | 0.07% | 262,694 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $611,969 | 0.07% | 62,766 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $567,778 | 0.07% | 49,031 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $563,186 | 0.07% | 312,881 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $536,001 | 0.06% | 400,000 | Common | SOLE |
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $503,580 | 0.06% | 157,862 | Common | SOLE |
| 89237H209 | — | TRACON PHARMACEUTICALS INC | $492,265 | 0.06% | 2,765,530 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $326,958 | 0.04% | 530,776 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $315,069 | 0.04% | 188,664 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $295,539 | 0.04% | 129 | PUT | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $272,093 | 0.03% | 32,547 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $243,418 | 0.03% | 10,862 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $213,767 | 0.03% | 318,591 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $197,000 | 0.02% | 500 | CALL | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $191,281 | 0.02% | 591,676 | Common | SOLE |
| 16385C104 | — | CHEMOMAB THERAPEUTICS LTD | $190,986 | 0.02% | 213,392 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $177,021 | 0.02% | 39 | CALL | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $132,767 | 0.02% | 18,647 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $121,107 | 0.01% | 40,369 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $76,460 | 0.01% | 15,292 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $67,793 | 0.01% | 21,590 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $58,080 | 0.01% | 4,000 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $57,459 | 0.01% | 20,448 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $47,736 | 0.01% | 12,116 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $37,576 | 0.00% | 11 | PUT | SOLE |
| 31773D200 | FNCHQ | FINCH THERAPEUTICS GROUP INC | $35,149 | 0.00% | 6,892 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $32,074 | 0.00% | 14 | CALL | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $21,270 | 0.00% | 1,821 | Common | SOLE |
| 10501E201 | BCLIEUR | BRAINSTORM CELL THERAPEUTICS | $18,057 | 0.00% | 90,242 | Common | SOLE |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $6,215 | 0.00% | 35,420 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $5,050 | 0.00% | 2 | CALL | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $2,393 | 0.00% | 2,774 | Common | SOLE |
| 29604W207 | — | PHAXIAM THERAPEUTICS S A | $1,558 | 0.00% | 301 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.